Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
FDA-approved anti-inflammatory drug delays onset of ALS in mice

FDA-approved anti-inflammatory drug delays onset of ALS in mice

Hibernators reveal genetic clues to better understand and treat obesity, metabolic disorders

Hibernators reveal genetic clues to better understand and treat obesity, metabolic disorders

Study finds autism-related genetic mutations in aging brains of Alzheimer's patients

Study finds autism-related genetic mutations in aging brains of Alzheimer's patients

Oligomerix and Feinstein Institutes publish preclinical data of Alzheimer's disease treatment

Oligomerix and Feinstein Institutes publish preclinical data of Alzheimer's disease treatment

Extra virgin olive oil boosts brain power

Extra virgin olive oil boosts brain power

Skiing associated with reduced risk of vascular dementia but not Alzheimer’s

Skiing associated with reduced risk of vascular dementia but not Alzheimer’s

Aerobic exercise and heart-healthy diet may slow cognitive decline in older adults with CIND

Aerobic exercise and heart-healthy diet may slow cognitive decline in older adults with CIND

Stem cells do not take the day off on national holidays

Stem cells do not take the day off on national holidays

Studying the genomes of hibernating mammals could improve understanding and treatment of obesity

Studying the genomes of hibernating mammals could improve understanding and treatment of obesity

Air pollution associated with greater risk of glaucoma

Air pollution associated with greater risk of glaucoma

New hope for diagnosing, treating Alzheimer's disease

New hope for diagnosing, treating Alzheimer's disease

Researchers estimate MCI prevalence among U.S. Latinos

Researchers estimate MCI prevalence among U.S. Latinos

University of Sheffield receives Queen's Anniversary Prize for innovation in neuroscience

University of Sheffield receives Queen's Anniversary Prize for innovation in neuroscience

Gene linked to Alzheimer’s plays indirect role in increasing delirium risk

Gene linked to Alzheimer’s plays indirect role in increasing delirium risk

Ultrasound treatment could be safe and effective option for people with essential tremor

Ultrasound treatment could be safe and effective option for people with essential tremor

Study uncovers new Alzheimer's risk gene

Study uncovers new Alzheimer's risk gene

Air pollution associated with memory decline and Alzheimer's-like brain atrophy

Air pollution associated with memory decline and Alzheimer's-like brain atrophy

Inflammatory processes drive progression of neurodegenerative brain diseases

Inflammatory processes drive progression of neurodegenerative brain diseases

Newly developed ChiTaRS database can collect cases of druggable fusion targets

Newly developed ChiTaRS database can collect cases of druggable fusion targets

Facebook live: Intimate lessons from the front lines of family caregiving

Facebook live: Intimate lessons from the front lines of family caregiving

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.